ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugBridgeBio International GmbH
BridgeBio International GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

BridgeBio International GmbH is a biopharmaceutical company that develops medicines for genetic conditions and manages a pipeline of investigational candidates and approved therapies. The organization uses a hub‑and‑spoke model, partners with academic institutions, and conducts clinical research and trials.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

BridgeBio International GmbH

✓ Offered7
Research and Development Pipeline
Late-stage and preclinical development of medicines for genetic diseases, including Acoramidis, BBP-418, Encaleret, Infigratinib, BBP-812 and Depleter.
Approved Medicines
Marketed medicines Attruby® (acoramidis) and NULIBRY® (fosdenopterin) for genetic and rare diseases.
Clinical Studies
Clinical studies on rare genetic diseases, including ACT-EARLY, PROPEL and ACCEL, to evaluate investigational therapies and their effectiveness.
Research and Publications
Scientific presentations, publications and peer-reviewed materials on molecules, diseases and research types in the field of rare genetic diseases.
Genetic Testing Programmes
Genetic Testing Programme for ADH1 and hypoparathyroidism, with separate information for patients and healthcare professionals.
Patient Access Support
Support after the prescription of BridgeBio medicines: insurance navigation, financial assistance, specialty-pharmacy handling and ongoing guidance.
Patient Support and Advocacy Information
Referrals to support and advocacy organizations for ATTR-CM, ATTRv, Achondroplasia, Hypochondroplasia, LGMD2I/R9, ADH1 and Canavan Disease.
Trust & reputation

ranQ Trust Score of BridgeBio International GmbH: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

BridgeBio International GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
BridgeBio International GmbH scores 57.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
BridgeBio International GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
BridgeBio International GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

BridgeBio International GmbH reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once BridgeBio International GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

BridgeBio International GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BridgeBio International GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BridgeBio International GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Landis + Gyr-Strasse 1
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-422.229.719
Founded
2024 · 2 years
Last commercial register change
October 22, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    CP
    Crinetics Pharmaceuticals Europe GmbH
    Zug
    KP
    KalVista Pharmaceuticals Switzerland GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    IS
    Insmed Switzerland GmbH
    Zug
    KP
    Kiniksa Pharmaceuticals, GmbH
    Zug
    SI
    Sarepta International Holdings GmbH
    Zug
    TP
    Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
    Zug
    ST
    SpringWorks Therapeutics Europe GmbH
    Zug